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NCID’s laboratory response
• Establishing coordination 
activities in a Emergency 
Operations Center (EOC)
• Monitoring/managing laboratory 
testing
• Dealing with issues as they 
arose
Organization of the Emergency 
Operations Center (EOC)
• Established 10/13/01
• Staff provided 24/7:  2-12 hour or 3-8 hour 
shifts
• BPRP had operational lead
• Preparedness and response activities 
conducted concurrently
• Written records maintained at all levels
EOC Staffing
• “A teams” with various skill sets identified in each 
CIO
• Line of authority resides within EOC structure and not 
dictated by CDC position or CIO
• Volunteer lists compiled by activity
• Coverage:
– 24/7 coverage in person or “on call” for about 1 month
– 16/7 coverage for about 3-4 weeks
– 12/5 coverage for about 2-3 weeks
EOC Operational Design
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• Assist NCID laboratories with personnel, supplies, space, etc. 
in responding to testing needs
• Chair daily meetings to discuss laboratory results
• Coordinate receipt of specimens
• Ensure laboratory reporting was coordinated
• Coordinate daily calls with Federal partners
• Ensure personnel were available to answer lab questions
• Develop and track documents regarding laboratory testing
• Deal with daily issues for information, coordination, 
communication
• Communicate with APHL and LRN partners
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NCID Laboratories Testing Anthrax 
Specimens
• Rapid Response and Rapid Technology Laboratory 
(BPRP)
• Epidemiologic Investigations Laboratory (DBMD)
• Anthrax Vaccine Research Program (DBMD)
• Infectious Diseases Pathology Activity (DVRD)
• Level A Laboratory (DHQP)
Laboratory Tests in NCID Laboratories
• Gram stain
• Culture
– colony morphology, hemolysis; motility; sporulation
• Culture confirmation
– Gamma phage assay

































(EOC field teams, 










– Level A laboratory
• Environmental 
specimens
– Level A laboratory
• Culture for 
confirmation
– Level B laboratory
• Powders
– Level B laboratory
• BSL-2 laboratory and 
practices
• BSL-2 laboratory; 
BSL-3 practices
• BSL-2 laboratory: 
BSL-3 practices
• BSL-3 laboratory and 
practices
Challenges
• Planning for laboratory needs
• Result reporting
– CDC’s information systems
– Single conduit for approving 
results
• Case definition
• Providing timely documents
• Information flow
• Communication 
Challenge: Planning for Laboratory 
Needs
• Specimen load inpredictable
• Large influx in specimens resulted in backlogs
– Logging in and aliquotting
– Testing
– Timely reporting of results
• Trained personnel in limited supply
• Rapid access to supplies and reagents
• Spaces to test hundreds of specimens needed
• Field teams deployed for some environmental testing
Challenges:  Laboratory Result Reporting 
(CDC)
• No commonly-used system for reporting in 
NCID
• Multiple specimen ID numbers
• Needed to develop integrated specimen 




Challenges:  Patient Results Reporting
• Daily meetings to report results by specimen
• Single point-of-contact to “bless” results—call 
cases
• Priority test results communicated through 
point-of-contact, then to field teams
• Results from CDC reported to 
requestor/patient prior to press releases
Challenge:  Case Definition
• Many specimens taken after antibiotics administered
• Positive results based on culture
• PCR results used only for evaluation of the method
• Histology and immunohistochemistry provided some 
information about presence of anthrax in tissues
• Serology (unvalidated test) results were often positive 
when culture was negative:  how to interpret??
• Cases identified based on clinical, epidemiologic, and 
laboratory data
Challenge:  Providing Timely Documents
• Laboratory protocols available in public (Level A) and 
secure (Levels B and C) websites; modifications 
required further clearance
• Information about laboratory tests, rapid detection 
technologies, etc. was needed
• Personnel most knowledgeable about technical 
laboratory issues were overworked in lab
• Review of all CDC communications required multiple 
approvals
• Single point-of-contact for final review of all 
documents required
Challenge:  Information Flow
• Communication with media through designated 
persons
• All laboratory results were provided to field teams; 
CDC did not verify results until all parties were 
notified
• Contract labs reported “presumptive positive” results; 
media reported results prior to originator receiving 
them
• Confidential reports need better levels of control
Challenge:  Communication
• Communication between boxes within the EOC
• Understanding of roles/responsibilities in EOC boxes
• Communication with field teams (specimens, e.g.)
• Communication with Federal partners
• Communication with media
• Communication with state partners and others 
Lessons Learned
• Surge capacity is essential (trained staff, space, 
supplies, reagents, etc.)
• Effective laboratory information system (specimen 
management) is critical
• Planning based on real scenarios is critical
• Communication about results must be confidential 
and provided through single point-of-contact
• Documents should be prepared in advance of event
• Technical experts to respond to inquiries are 
essential
